Eurand (Milan, Italy) Acquires Specialty Cystic Fibrosis Company
PHILADELPHIA, Dec. 3, 2007 (PRIME NEWSWIRE) -- Eurand N.V. (NasdaqGM:EURX - News) announced today that Eurand Pharmaceuticals, Inc. has acquired the SourceCF family of companies (``SourceCF'') for $6.6 million in cash. The sellers also have the potential to receive up to an additional $3 million in deferred and milestone payments from Eurand after 24 months.